NAV
$31.92
AUM
$135.7M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +9.52% | +2.80% | +8.36% | +20.14% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 2.26% |
| 2 | TSM | Taiwan Semiconductor Manufacturing Co Ltd ADR | 1.50% |
| 3 | UBSG.SW | UBS Group AG Registered Shares | 1.27% |
| 4 | HSBA.L | HSBC Holdings PLC | 1.14% |
| 5 | SHEL.L | Shell PLC | 1.04% |
| 6 | SU.PA | Schneider Electric SE | 0.94% |
| 7 | AZN.L | AstraZeneca PLC | 0.89% |
| 8 | GSK.L | GSK PLC | 0.81% |
| 9 | NOVN.SW | Novartis AG Registered Shares | 0.81% |
The fund has a non-fundamental policy to invest, under normal circumstances, at least 80% of the value of its net assets plus borrowings for investment purposes in equity securities economically tied to countries (other than the U.S.) with developed markets. It invests principally in equity securities, including common stocks and preferred stocks, issued by companies economically tied to developed markets countries, other than the U.S., and in depositary receipts representing shares in such companies.
Inception Date: 2025-05-13